Dongwha Pharm.Co.,Ltd
000020.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
349
Cost of Revenue
188
Gross Profit
161
Gross Margin
46.1%
Operating Income
10
Operating Margin
2.9%
Net Income
4
Net Margin
1.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
22
EBITDA Margin
6.2%
2023
12/31/2023
Revenue
271
Cost of Revenue
128
Gross Profit
143
Gross Margin
52.7%
Operating Income
19
Operating Margin
7.0%
Net Income
21
Net Margin
7.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
37
EBITDA Margin
13.5%
2022
12/31/2022
Revenue
255
Cost of Revenue
120
Gross Profit
136
Gross Margin
53.2%
Operating Income
22
Operating Margin
8.8%
Net Income
15
Net Margin
6.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
29
EBITDA Margin
11.2%
2021
12/31/2021
Revenue
220
Cost of Revenue
108
Gross Profit
112
Gross Margin
51.0%
Operating Income
17
Operating Margin
7.7%
Net Income
13
Net Margin
6.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
30
EBITDA Margin
13.5%
2020
12/31/2020
Revenue
204
Cost of Revenue
100
Gross Profit
104
Gross Margin
51.0%
Operating Income
17
Operating Margin
8.5%
Net Income
21
Net Margin
10.5%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
34
EBITDA Margin
16.4%